Welltory Secures $2M in Growth Funding from Braavo to Expand Chronic Disease Support Services

icon币界网
Share
AI summary iconSummary
Welltory announced a $2 million funding round from Braavo Capital to scale its chronic disease support service, Welltory Care. The investment supports ecosystem growth and strengthens the partnership, which has already driven product development and market expansion. With 18 million users, Welltory uses digital phenotyping to connect patients with similar conditions. The company plans to launch Care groups for migraine, long COVID, chronic fatigue, and IBS in the coming year.
CoinMarketCap reports:

Redwood City, California, USA, October 8, 2026 /PRNewswire/ -- Consumer health app Welltory announced it has secured a $2 million growth investment from long-term partner Braavo Capital to expand its service for chronic disease patients, Welltory Care. Welltory stated that it has a user base of 18 million.

This funding round marks the latest phase in the long-term partnership between the two parties. Welltory stated that during their collaboration, Braavo has provided millions of dollars in growth financing to support the company’s expansion into new products and markets.

Welltory Care brings together individuals with similar symptoms, physiological traits, and daily limitations, combining peer experiences with personal data, research, and medical expertise. Welltory uses digital phenotyping—the analysis of wearable device data and user-reported experiences—to identify groups with similar characteristics and build more targeted support around their needs.

Veranika Zdanovich, Chief Business Officer at Welltory, said: “Most health products are designed for the average user, but chronic illness is not an ‘average’ experience. With 18 million users, we can bring together people with remarkably similar physiological traits and daily limitations, and then build research and tools around what this specific group truly needs.”

Three months ago, Welltory launched its first Energy Lab group, consisting of 100 individuals experiencing post-exertional malaise (PEM). Due to high engagement, the team plans to expand the group to 500 participants, while clinical outcomes will be collected through an IRB-approved study.

Welltory funds its research and product development with its own resources, while Braavo’s funding will primarily support the growth of its Care business and hiring.

Mark Loranger, CEO of Braavo Capital, said: “Welltory has been a long-term partner of Braavo, and it’s incredibly rewarding to see the company continue to grow while staying true to its mission. We’re proud to have played a role in this journey and to support initiatives that improve the health and well-being of millions of people.”

Over the next year, Welltory plans to launch Care groups for migraines, long COVID, chronic fatigue, and irritable bowel syndrome.

About Welltory

Welltory helps people understand their physiological condition and health status using data from wearable devices and heart rate variability analysis.

About Braavo Capital

Braavo Capital is a non-dilutive financing platform for mobile app and gaming companies. Since 2015, Braavo has deployed over $2 billion in growth financing to more than 10,000 apps.

Media contacts: Anna Butuzova, [email protected]; Dion Pllana, [email protected]

Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.